Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Shabber Zaveri"'
Autor:
S. P. Somashekhar, Shabber Zaveri, Devanhalli Govinda Vijay, Palanki Satya Dattatreya, Rajeev Kumar, Fatma Islahi, Charu Bahl
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1363-1369 (2020)
PURPOSEThere are new advancements in the modulation of the treatment of patients with early-stage breast cancer, including the use of several molecular profiling tests to identify or select those patients who require additional adjuvant chemotherapy
Externí odkaz:
https://doaj.org/article/59d088125509491e97e794066823e4d0
Publikováno v:
Indian Journal of Anaesthesia, Vol 59, Iss 12, Pp 807-810 (2015)
Malignant pleural mesothelioma is a rare tumour with survival of 9-17 months after diagnosis. Radical surgical resection by extra-pleural pneumonectomy combined with hyperthermic intrathoracic chemotherapy has shown to improve patient survival and be
Externí odkaz:
https://doaj.org/article/82d3214a159a4b87b41b9ce7a299e312
Autor:
Shabber Zaveri, B. C. Ashok, Jaiswal Richa, Sushmita H. Rakshit, Prasad Archa, K. R. Ashwin, S.P. Somashekhar, C Rohit Kumar
Publikováno v:
Indian Journal of Surgery. 84:765-770
Autor:
K. R. Ashwin, Archa Prasad, Shilpa Ramchandra, Sai Pillarisetti, Sushmita H. Rakshit, Rupa Ananthasivan, Richa Jaiswal, S.P. Somashekhar, Rohit Kumar, Shabber Zaveri
Publikováno v:
Indian Journal of Surgery. 84:758-764
Newer adjuncts in breast conservation surgery are striving for more precise excision of these cancerous lesions. This study evaluates two such techniques, preoperative ultrasound-guided lesion clipping and skin marking, and their effects on the surgi
Autor:
Devanhalli Govinda Vijay, Charu Bahl, Fatma Islahi, Rajeev Kumar, Palanki Satya Dattatreya, Shabber Zaveri, S.P. Somashekhar
Publikováno v:
JCO Global Oncology
PURPOSE There are new advancements in the modulation of the treatment of patients with early-stage breast cancer, including the use of several molecular profiling tests to identify or select those patients who require additional adjuvant chemotherapy
Publikováno v:
European Journal of Surgical Oncology. 46:577-581
Introduction Morbidity associated with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is due to the synergistic effect of cytoreduction, effect hyperthermia and the cytotoxic agents used for HIPEC. This study was d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shabber Zaveri, Mukurdipi Ray, Mahesh D. Patel, Dileep Damodaran, Ramakrishnan Ayloor Seshadri, Sanket Mehta, Aditi Bhatt, Praveen Kammar, Snita Sinukumar
Publikováno v:
Indian Journal of Surgical Oncology. 10:49-56
Cytoreductive surgery (CRS) and HIPEC results in a median disease-free survival (DFS) of 12–15 months, overall survival (OS) of 23–63 months, and cure in around 15% of patients with colorectal peritoneal metastases (CPM). The wide variation in OS
Autor:
Aditi Bhatt, Snita Sinukumar, Sanket Mehta, Praveen Kammar, Mukurdipi Ray, Dileep Damodaran, Shabber Zaveri, Ramakrishnan As
Publikováno v:
Indian Journal of Surgical Oncology. 10:65-70
To evaluate the clinical outcomes of patients of pseudomyxoma peritonei of appendiceal origin undergoing cytoreductive surgery and HIPEC. Data collected from members, an independent collaborative group of Indian surgeons specializing in the managemen
Autor:
Amit Rauthan, Poonam Patil, Nitin Yashas Murthy, S.P. Somashekhar, Shabber Zaveri, Rajashri Aswath, Prathyush V, Chinnu Jomi
Publikováno v:
Journal of Clinical Oncology. 40:e16117-e16117
e16117 Background: Firstline treatment of advanced hepatocellular carcinoma (HCC) till recently has been sorafenib or lenvatinib. Lenvatinib, due to its better tolerability and efficacy (in PFS) over sorafenib, is our preferred first line treatment.